Cadrenal Therapeutics, Inc. (CVKD) Free cash flow 2023–2025
Cadrenal Therapeutics, Inc. (CVKD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$12.6MFY2025 · since FY2023: -$3.5M → -$12.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.6M | -71.2% |
| FY2024 | -$7.4M | -108.4% |
| FY2023 | -$3.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice